UNSPSC 85764554: Alteration of lower jaw, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to alteration of lower jaw, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0W053ZZ

UNSPSC 85764554 Alteration of lower jaw, percutaneous approach is a Commodity code that shows little relevant recent activity aligned with its stated clinical scope. The recent state and local opportunities tagged under this code cover occupational medical surveillance, pharmacy benefit management, temporary health professional staffing, independent disability medical evaluations, surgical carve-out benefit programs, and youth detention healthcare services — none of which involve orthognathic or maxillofacial surgical intervention. The code's nominal scope does not match the work being actively solicited in the sample, suggesting either a tagging anomaly in the sourcing system or that state and local procurement offices rarely issue standalone solicitations for this specific procedure.

The opportunities that do appear in the dataset span diverse issuing bodies: the City of Phoenix Retirement Office (Arizona), the City of Long Beach (California), the Washington State Department of Transportation, Harris County Juvenile Probation Department (Texas), Collier County (Florida), and the County of Santa Clara Health System (California). Geographic representation includes Arizona, California, Florida, Texas, and Washington. Representative recent activity includes the City of Phoenix's RFP for independent medical evaluation services (due October 16, 2026), the Washington State Department of Transportation's RFP for occupational medical surveillance services (due October 9, 2026), and the City of Long Beach's RFP for surgical and medical procedure carve-out benefits (due October 7, 2026). None of these solicitations address the Commodity code's stated clinical content, indicating that firms targeting this code should verify tagging accuracy with issuing bodies before pursuing opportunities or building internal capability around this procedure type.